No increased risk of hepatocellular carcinoma recurrence in patients following interferon-free, direct acting anti-viral treatment for hepatitis C virus: a cohort study using large-scale administrative medical claims data

被引：2
|
作者：
Telep, L. E. [1 ]
Muramoto, D. [1 ]
Osinusi, A. [1 ]
Brainard, D. M. [1 ]
Reddy, K. R. [2 ]
Singer, A. W. [1 ]
Chokkalingam, A. P. [1 ]
机构：
[1] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[2] Univ Penn, Div Gastroenterol & Hepatol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31469-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-275
引用
收藏
页码：S533 / S533
页数：1
相关论文
共 33 条
  • [1] Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: fact or fiction?
    Liu, Chen-Hua
    Kao, Jia-Horng
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S192 - S195
  • [2] Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment
    Ogawa, E.
    Furusyo, N.
    Nomura, H.
    Dohmen, K.
    Higashi, N.
    Takahashi, K.
    Kawano, A.
    Azuma, K.
    Satoh, T.
    Nakamuta, M.
    Koyanagi, T.
    Kato, M.
    Shimoda, S.
    Kajiwara, E.
    Hayashi, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (01) : 104 - 113
  • [3] Interferon-free direct-acting antiviral therapy decreases the rate of hepatocellular carcinoma recurrence in patients with chronic hepatitis C and advanced fibrosis
    Virlogeux, V.
    Pradat, P.
    Hartig-Lavie, K.
    Bailly, F.
    Maynard, M.
    Ouziel, G.
    Poinsot, D.
    Lebosse, F.
    Ecochard, M.
    Radenne, S.
    Benmakhlouf, S.
    Koffi, J.
    Lack, P.
    Scholtes, C.
    Uhres, A. -C.
    Ducerf, C.
    Mabrut, J. -Y.
    Rode, A.
    Levrero, M.
    Combet, C.
    Merle, P.
    Zoulim, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S745 - S745
  • [4] Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients
    Luan, Chih-Hsuan
    Su, Pin-Shuo
    Chu, Chi-Jen
    Lin, Chung-Chi
    Su, Chien-Wei
    Luo, Jiing-Chyuan
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Shou-Dong
    Wang, Yuan-Jen
    Lee, Fa-Yauh
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2024, 87 (04) : 357 - 368
  • [5] Interval between hepatocellular carcinoma treatment and interferon-free direct-acting antiviral agents against hepatitis C is necessary to suppress tumor recurrence
    Iida, Hiroya
    Osaki, Rie
    Fujimoto, Takehide
    Maehira, Hiromitsu
    Mori, Haruki
    Kitamura, Naomi
    Andoh, Akira
    Tani, Masaji
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (01) : 99 - 105
  • [6] Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma
    Ismail, Mohamed Saleh
    Mohamed, Islam
    Polychronopoulou, Efstathia
    Goss, John A.
    Kuo, Yong-Fang
    Kanwal, Fasiha
    Jalal, Prasun K.
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 701 - 711
  • [7] Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong
    Chow, Victor Yung Sin
    Cheung, Veronica Wing I.
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1195 - S1195
  • [8] Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong
    Victor Yung Sin Chow
    Wing I Cheung
    BMC Gastroenterology, 24
  • [9] Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong
    Chow, Victor Yung Sin
    Cheung, Wing, I
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [10] Hepatocellular carcinoma development in hepatitis C virus patients who achieved sustained viral response by interferon therapy and direct anti-viral agents therapy
    Nagaoki, Yuko
    Aikata, Hiroshi
    Kobayashi, Tomoki
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Chayama, Kazuaki
    HEPATOLOGY, 2016, 64 : 424A - 424A
1234